{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:45Z","timestamp":1792601625114,"version":"4.5.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231209","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T13:27:26Z","timestamp":1586179646000},"page":"e0231209","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5583-741X","authenticated-orcid":true,"given":"Pernille Rudebeck","family":"Mogensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine","family":"Grell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik Malthe","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Ole","family":"Wolthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Sloth","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Vaag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Leth","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"issue":"27","key":"pone.0231209.ref001","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration","volume":"33","author":"C-H Pui","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"pone.0231209.ref002","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","article-title":"Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus","volume":"17","author":"K Schmiegelow","year":"2016","journal-title":"Lancet Oncol"},{"key":"pone.0231209.ref003","first-page":"15","author":"KC Oeffinger","year":"2006","journal-title":"Chronic Health Conditions in Adult Survivors of Childhood Cancer for the Childhood Cancer Survivor Study*"},{"key":"pone.0231209.ref004","author":"L Diller","journal-title":"Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings"},{"issue":"5","key":"pone.0231209.ref005","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1194\/jlr.M072207","article-title":"Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors","volume":"58","author":"S Morel","year":"2017","journal-title":"J Lipid Res"},{"issue":"3","key":"pone.0231209.ref006","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bjh.12754","article-title":"Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia\u2014From the St. Jude Lifetime Cohort","volume":"165","author":"KA Nottage","year":"2014","journal-title":"Br J Haematol"},{"issue":"2","key":"pone.0231209.ref007","first-page":"123","article-title":"Hyperlipidemia in acute lymphoblastic leukemia","volume":"14","author":"PR Blackett","year":"1984","journal-title":"Ann Clin Lab Sci"},{"issue":"15","key":"pone.0231209.ref008","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.ejca.2014.06.023","article-title":"Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia","volume":"50","author":"D Bhojwani","year":"2014","journal-title":"Eur J Cancer"},{"issue":"12","key":"pone.0231209.ref009","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/1097-0142(19941215)74:12<3234::AID-CNCR2820741224>3.0.CO;2-1","article-title":"Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase","volume":"74","author":"PG Steinherz","year":"1994","journal-title":"Cancer"},{"issue":"8","key":"pone.0231209.ref010","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.leu.2400703","article-title":"Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity","volume":"11","author":"N Hoogerbrugge","year":"1997","journal-title":"Leukemia"},{"issue":"3","key":"pone.0231209.ref011","article-title":"Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia","volume":"8","author":"H Cohen","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"pone.0231209.ref012","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2141.2007.06677.x","article-title":"Thrombosis and acute lymphoblastic leukaemia","volume":"138","author":"JH Payne","year":"2007","journal-title":"Br J Haematol"},{"issue":"22","key":"pone.0231209.ref013","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2018-01-827949","article-title":"Thromboembolism in acute lymphoblastic leukemia: Results of nopho all2008 protocol treatment in patients aged 1 to 45 years","volume":"131","author":"CU Rank","year":"2018","journal-title":"Blood"},{"issue":"3","key":"pone.0231209.ref014","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/jth.13236","article-title":"Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: A Nordic Society of Pediatric Hematology and Oncology (NOPHO) study","volume":"14","author":"R Tuckuviene","year":"2016","journal-title":"J Thromb Haemost"},{"key":"pone.0231209.ref015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2018.02.150","article-title":"Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia","volume":"165","author":"S Prasca","year":"2018","journal-title":"Thromb Res"},{"issue":"8","key":"pone.0231209.ref016","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2010-10-311969","article-title":"CME article Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia","volume":"117","author":"JD Kawedia","year":"2011","journal-title":"Blood"},{"issue":"5","key":"pone.0231209.ref017","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.3324\/haematol.2016.160507","article-title":"Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia","volume":"102","author":"SS Mogensen","year":"2017","journal-title":"Haematologica"},{"issue":"20","key":"pone.0231209.ref018","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMra1505202","article-title":"Acute Pancreatitis","volume":"375","author":"CE Forsmark","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0231209.ref019","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00004836-200301000-00016","article-title":"Pancreatic and biliary diseases: Issues in hyperlipidemic pancreatitis","volume":"36","author":"D Yadav","year":"2003","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"pone.0231209.ref020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pbc.26183","article-title":"Asparaginase-associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemia","volume":"64","author":"RA Raja","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"pone.0231209.ref021","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/2050640618755002","article-title":"Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management","volume":"6","author":"N de Pretis","year":"2018","journal-title":"United Eur Gastroenterol J"},{"key":"pone.0231209.ref022","first-page":"e26891","article-title":"Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens","author":"CC Denton","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"pone.0231209.ref023","first-page":"1","article-title":"Association between body mass index and pancreatitis in children with acute lymphoblastic leukemia","author":"PR Mogensen","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"pone.0231209.ref024","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood.V89.6.1886","article-title":"Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"2","key":"pone.0231209.ref025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P","article-title":"Blood lipid profiles in children with acute lymphoblastic leukemia","volume":"83","author":"JM Halton","year":"1998","journal-title":"Cancer"},{"issue":"5","key":"pone.0231209.ref026","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00043426-200405000-00006","article-title":"Serum lipid alterations in acute lymphoblastic leukemia of childhood","volume":"26","author":"M Moschovi","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"pone.0231209.ref027","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(82)90543-5","article-title":"Plasma lipid alterations in leukemia and lymphoma","volume":"72","author":"RJ Spiegel","year":"1982","journal-title":"Am J Med"},{"issue":"4","key":"pone.0231209.ref028","first-page":"343","article-title":"Return to normal values of lipid pattern after effective chemotherapy in acute lymphoblastic leukemia","volume":"81","author":"D Scribano","year":"1996","journal-title":"Haematologica"},{"key":"pone.0231209.ref029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cca.2015.01.038","article-title":"Revisiting the dyslipidemia associated with acute leukemia","volume":"444","author":"H Usman","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"15","key":"pone.0231209.ref030","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1200\/JCO.2006.07.7792","article-title":"Obesity and outcome in pediatric acute lymphoblastic leukemia","volume":"25","author":"AM Butturini","year":"2007","journal-title":"J Clin Oncol"},{"issue":"26","key":"pone.0231209.ref031","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2014-08-595389","article-title":"Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia","volume":"124","author":"E Orgel","year":"2015","journal-title":"Blood"},{"issue":"2","key":"pone.0231209.ref032","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1038\/bcj.2017.11","article-title":"The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia","volume":"7","author":"HM Eissa","year":"2017","journal-title":"Blood Cancer J"},{"issue":"6","key":"pone.0231209.ref033","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/ijc.23176","article-title":"Overweight and obesity and incidence of leukemia: A meta-analysis of cohort studies","volume":"122","author":"SC Larsson","year":"2008","journal-title":"Int J Cancer"},{"issue":"2","key":"pone.0231209.ref034","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.12562","article-title":"Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia","volume":"96","author":"N Toft","year":"2016","journal-title":"Eur J Haematol"},{"key":"pone.0231209.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2012.721519","article-title":"Recommended Nordic paediatric reference intervals for 21 common biochemical properties","volume":"73","author":"L Hilsted","year":"2012","journal-title":"Scand J Clin Lab Investig"},{"issue":"5","key":"pone.0231209.ref036","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1373\/clinchem.2011.177741","article-title":"Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children","volume":"58","author":"DA Colantonio","year":"2012","journal-title":"Clin Chem"},{"issue":"4","key":"pone.0231209.ref037","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/00365513.2012.667571","article-title":"Reference intervals on the Abbot Architect for serum thyroid hormones, lipids and prolactin in healthy children in a population-based study","volume":"72","author":"M Aldrimer","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"pone.0231209.ref038","unstructured":"World Health organisation. Strategy on Diet, physical activity and health [Internet]. Available from: https:\/\/www.who.int\/dietphysicalactivity\/childhood_what\/en\/"},{"issue":"2","key":"pone.0231209.ref039","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.ijo.0801515","article-title":"Body mass index of 0 to 45-y-old Danes: Reference values and comparison with published European reference values","volume":"25","author":"K Nysom","year":"2001","journal-title":"Int J Obes"},{"key":"pone.0231209.ref040","unstructured":"Software S. No Copyright \u00a9 [year of copyright] SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, NC,USA."},{"key":"pone.0231209.ref041","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2017"},{"issue":"2","key":"pone.0231209.ref042","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.celrep.2016.03.020","article-title":"Tumor-Induced Hyperlipidemia Contributes to Tumor Growth","volume":"15","author":"J Huang","year":"2016","journal-title":"Cell Rep"},{"issue":"5","key":"pone.0231209.ref043","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"M Petruzzelli","year":"2016","journal-title":"Genes Dev"},{"issue":"2","key":"pone.0231209.ref044","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00075197-200203000-00006","article-title":"Changes in the concentration and composition of plasma lipoproteins during the acute phase response","volume":"5","author":"YA Carpentier","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"30","key":"pone.0231209.ref045","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1200\/JCO.2007.13.1078","article-title":"Obesity in dose calculation: A mouse or an elephant?","volume":"25","author":"H Gurney","year":"2007","journal-title":"J Clin Oncol"},{"key":"pone.0231209.ref046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep27966","article-title":"Body surface area formulae: An alarming ambiguity","volume":"6","author":"G Redlarski","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"pone.0231209.ref047","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.3324\/haematol.2015.130500","article-title":"Comment on \u201cAcute lymphoblastic leukemia and adiponcosis\u201d by M. Bifulco and AM Malfitano","volume":"100","author":"SMF Pluijm","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"pone.0231209.ref048","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.3324\/haematol.2014.122168","article-title":"Comment on \u201cthe negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia","volume":"100","author":"M Bifulco","year":"2015","journal-title":"Haematologica"},{"issue":"0","key":"pone.0231209.ref049","doi-asserted-by":"crossref","first-page":"444","DOI":"10.12688\/f1000research.10768.1","article-title":"Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy","volume":"6","author":"K Schmiegelow","year":"2017","journal-title":"F1000Research"},{"issue":"6","key":"pone.0231209.ref050","doi-asserted-by":"crossref","first-page":"e0158225","DOI":"10.1371\/journal.pone.0158225","article-title":"Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone","volume":"11","author":"LT Warris","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"pone.0231209.ref051","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1210\/jcem.86.8.7764","article-title":"Effect of Glucocorticoid Therapy on Energy Intake in Children Treated for Acute Lymphoblastic Leukemia","volume":"86","author":"JJ Reilly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"pone.0231209.ref052","first-page":"40","volume":"15","author":"JJ Reilly","year":"2009","journal-title":"Obesity during and after Treatment for Childhood Cancer"},{"issue":"4","key":"pone.0231209.ref053","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/pbc.24364","article-title":"Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia","volume":"60","author":"EJ Chow","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"21","key":"pone.0231209.ref054","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"PM Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"19","key":"pone.0231209.ref055","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.18.01877","article-title":"Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study","volume":"37","author":"BK Albertsen","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T13:28:06Z","timestamp":1586179686000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231209"}},"subtitle":[],"editor":[{"given":"Obul Reddy","family":"Bandapalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231209","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]}}}